The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
NCT05144087
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Asthma; Eosinophilic
Sponsor
University Hospital Southampton NHS Foundation Trust
Collaborators
[object Object]
[object Object]